SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-053503
Filing Date
2008-03-12
Accepted
2008-03-12 06:07:32
Documents
10
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 844617
2 AMENDMENT TO EMPLOYMENT AGREEMENT BETWEEN REGISTRANT AND SUNIL BHONSLE dex1046.htm EX-10.46 15905
3 AMENDMENT TO EMPLOYMENT AGREEMENT BETWEEN REGISTRANT AND ROBERT E. FARRELL dex1047.htm EX-10.47 15902
4 LIST OF SUBSIDIARIES dex21.htm EX-21 2917
5 CONSENT OF ODENBERG, ULLAKKO, MURANISHI & CO. LLP dex231.htm EX-23.1 2089
6 CERTIFICATION OF CEO PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A) dex311.htm EX-31.1 9309
7 CERTIFICATION OF CFO PURSUANT TO RULE 13A-14(A) AND RULE 15D-14(A) dex312.htm EX-31.2 9360
8 CERTIFICATION OF CEO AND CFO PURSUANT TO 18 U.S.C. 1350 dex32.htm EX-32 4831
9 GRAPHIC g12645g72t14.jpg GRAPHIC 8491
10 GRAPHIC g12645g84c28.jpg GRAPHIC 56132
  Complete submission text file 0001193125-08-053503.txt   995727
Mailing Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080
Business Address 400 OYSTER POINT BLVD SUITE 505 SAN FRANCISCO CA 94080 4152444990
TITAN PHARMACEUTICALS INC (Filer) CIK: 0000910267 (see all company filings)

IRS No.: 943171940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-13341 | Film No.: 08682294
SIC: 2836 Biological Products, (No Diagnostic Substances)